Florida Opportunity Fund
The Florida Opportunity Fund primarily invests in a diversified portfolio of seed and early-stage venture capital funds that target investment opportunities within Florida. Its strategy aims to increase the availability of capital for emerging companies in strategic sectors such as life sciences, information technology, and advanced manufacturing, and it also makes direct investments in Florida businesses and infrastructure projects.
33% of their portfolio is in Healthcare. Deal activity increased 200% year-over-year (3 deals in the last 12 months). Their most common stage is seed (67% of deals). Average disclosed round size is $16.5M (across 8 rounds with reported amounts).
Portfolio
9
Fund Size
$108M
Top Stage
Seed
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Urban SDK | Growth | $65M | Feb 2026 |
 Beycome | Seed | $2.5M | Dec 2025 |
| WWorth | Seed | $20M | Mar 2025 |
 Myosin Therapeutics Inc. | Seed | $3M | Feb 2025 |
 Propense.ai | Seed | $3M | Mar 2024 |
 HealthSnap | Series B | $25M | Feb 2024 |
 Cyrano Therapeutics, Inc. | Series B | $9M | Jan 2024 |
| Myosin Therapeutics Inc. | Seed | — | Mar 2023 |
| Urban SDK | Seed | $4.5M | Jan 2022 |
Top Co-Investors
Last updated: 8 March 2026